RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Gross margin (%)

BrightPath Biotherapeutics Co., Ltd.JP:4594

Market cap
¥4.4B
P/E ratio
-3.6x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndGross margin (%) YoY (%)
Mar 31, 202597.2+29.57%
Mar 31, 202475+17.02%
Mar 31, 202364.1-18.33%
Mar 31, 202278.5+44.69%
Mar 31, 202154.2-10.30%
Mar 31, 202060.5+10.69%
Mar 31, 201954.6+393.40%
Mar 31, 201811.1+1147.73%
Mar 31, 20170.9-85.66%
Mar 31, 20166.2-7.57%
Mar 31, 20156.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)